aluates Reports

$ 0.0

Automative

Global Bispecific Antibody Drug Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-18C5839

Global Bispecific Antibody Drug Market Insights Forecast to 2028

BUY CHAPTERS

Global Bispecific Antibody Drug Market Research Report 2025

Code: QYRE-Auto-18C5839

Report

July 2025

Pages:91

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Amgen Inc

Sanofi

Pfizer Inc

Johnson & Johnson

Astrazeneca plc

AbbVie

Lindis Biotech

MacroGenics Inc

Genmab

Immunocore Ltd

Xencor

Merck

Affimed NV

Alphamab

Akeso, Inc.

BeiGene Ltd

Bispecific Antibody Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Bispecific Antibody Drug Market

The global market for Bispecific Antibody Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Bispecific Antibody Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bispecific Antibody Drug.

The Bispecific Antibody Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Bispecific Antibody Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bispecific Antibody Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Bispecific Antibody Drug Market Report

Report Metric	Details
Report Name	Bispecific Antibody Drug Market
CAGR	5%
Segment by Type	Fragment-Based IgG-Based
Segment by Application	Cancer Haemophilia Other Diseases
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Amgen, Sanofi, Pfizer, Johnson & Johnson, AstraZeneca, Abbvie, Lindis Biotech, MacroGenics, Genmab, Immunocore Limited, Xencor, Merck, Affimed, Alphamab, Akeso, BeiGene
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Bispecific Antibody Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Bispecific Antibody Drug Market report?

Ans: The main players in the Bispecific Antibody Drug Market are Roche, Amgen, Sanofi, Pfizer, Johnson & Johnson, AstraZeneca, Abbvie, Lindis Biotech, MacroGenics, Genmab, Immunocore Limited, Xencor, Merck, Affimed, Alphamab, Akeso, BeiGene

What are the Application segmentation covered in the Bispecific Antibody Drug Market report?

Ans: The Applications covered in the Bispecific Antibody Drug Market report are Cancer, Haemophilia, Other Diseases

What are the Type segmentation covered in the Bispecific Antibody Drug Market report?

Ans: The Types covered in the Bispecific Antibody Drug Market report are Fragment-Based, IgG-Based

Recommended Reports

Pharmaceutical Drugs

Pharmaceutical Equipment

Diagnostics & Therapies

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Bispecific Antibody Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Fragment-Based

1.2.3 IgG-Based

1.3 Market by Application

1.3.1 Global Bispecific Antibody Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Cancer

1.3.3 Haemophilia

1.3.4 Other Diseases

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Bispecific Antibody Drug Market Perspective (2020-2031)

2.2 Global Bispecific Antibody Drug Growth Trends by Region

2.2.1 Global Bispecific Antibody Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Bispecific Antibody Drug Historic Market Size by Region (2020-2025)

2.2.3 Bispecific Antibody Drug Forecasted Market Size by Region (2026-2031)

2.3 Bispecific Antibody Drug Market Dynamics

2.3.1 Bispecific Antibody Drug Industry Trends

2.3.2 Bispecific Antibody Drug Market Drivers

2.3.3 Bispecific Antibody Drug Market Challenges

2.3.4 Bispecific Antibody Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Bispecific Antibody Drug Players by Revenue

3.1.1 Global Top Bispecific Antibody Drug Players by Revenue (2020-2025)

3.1.2 Global Bispecific Antibody Drug Revenue Market Share by Players (2020-2025)

3.2 Global Bispecific Antibody Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Bispecific Antibody Drug Revenue

3.4 Global Bispecific Antibody Drug Market Concentration Ratio

3.4.1 Global Bispecific Antibody Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Bispecific Antibody Drug Revenue in 2024

3.5 Global Key Players of Bispecific Antibody Drug Head office and Area Served

3.6 Global Key Players of Bispecific Antibody Drug, Product and Application

3.7 Global Key Players of Bispecific Antibody Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Bispecific Antibody Drug Breakdown Data by Type

4.1 Global Bispecific Antibody Drug Historic Market Size by Type (2020-2025)

4.2 Global Bispecific Antibody Drug Forecasted Market Size by Type (2026-2031)

5 Bispecific Antibody Drug Breakdown Data by Application

5.1 Global Bispecific Antibody Drug Historic Market Size by Application (2020-2025)

5.2 Global Bispecific Antibody Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Bispecific Antibody Drug Market Size (2020-2031)

6.2 North America Bispecific Antibody Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Bispecific Antibody Drug Market Size by Country (2020-2025)

6.4 North America Bispecific Antibody Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Bispecific Antibody Drug Market Size (2020-2031)

7.2 Europe Bispecific Antibody Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Bispecific Antibody Drug Market Size by Country (2020-2025)

7.4 Europe Bispecific Antibody Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Bispecific Antibody Drug Market Size (2020-2031)

8.2 Asia-Pacific Bispecific Antibody Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Bispecific Antibody Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Bispecific Antibody Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Bispecific Antibody Drug Market Size (2020-2031)

9.2 Latin America Bispecific Antibody Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Bispecific Antibody Drug Market Size by Country (2020-2025)

9.4 Latin America Bispecific Antibody Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Bispecific Antibody Drug Market Size (2020-2031)

10.2 Middle East & Africa Bispecific Antibody Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Bispecific Antibody Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Bispecific Antibody Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche

11.1.1 Roche Company Details

11.1.2 Roche Business Overview

11.1.3 Roche Bispecific Antibody Drug Introduction

11.1.4 Roche Revenue in Bispecific Antibody Drug Business (2020-2025)

11.1.5 Roche Recent Development

11.2 Amgen

11.2.1 Amgen Company Details

11.2.2 Amgen Business Overview

11.2.3 Amgen Bispecific Antibody Drug Introduction

11.2.4 Amgen Revenue in Bispecific Antibody Drug Business (2020-2025)

11.2.5 Amgen Recent Development

11.3 Sanofi

11.3.1 Sanofi Company Details

11.3.2 Sanofi Business Overview

11.3.3 Sanofi Bispecific Antibody Drug Introduction

11.3.4 Sanofi Revenue in Bispecific Antibody Drug Business (2020-2025)

11.3.5 Sanofi Recent Development

11.4 Pfizer

11.4.1 Pfizer Company Details

11.4.2 Pfizer Business Overview

11.4.3 Pfizer Bispecific Antibody Drug Introduction

11.4.4 Pfizer Revenue in Bispecific Antibody Drug Business (2020-2025)

11.4.5 Pfizer Recent Development

11.5 Johnson & Johnson

11.5.1 Johnson & Johnson Company Details

11.5.2 Johnson & Johnson Business Overview

11.5.3 Johnson & Johnson Bispecific Antibody Drug Introduction

11.5.4 Johnson & Johnson Revenue in Bispecific Antibody Drug Business (2020-2025)

11.5.5 Johnson & Johnson Recent Development

11.6 AstraZeneca

11.6.1 AstraZeneca Company Details

11.6.2 AstraZeneca Business Overview

11.6.3 AstraZeneca Bispecific Antibody Drug Introduction

11.6.4 AstraZeneca Revenue in Bispecific Antibody Drug Business (2020-2025)

11.6.5 AstraZeneca Recent Development

11.7 Abbvie

11.7.1 Abbvie Company Details

11.7.2 Abbvie Business Overview

11.7.3 Abbvie Bispecific Antibody Drug Introduction

11.7.4 Abbvie Revenue in Bispecific Antibody Drug Business (2020-2025)

11.7.5 Abbvie Recent Development

11.8 Lindis Biotech

11.8.1 Lindis Biotech Company Details

11.8.2 Lindis Biotech Business Overview

11.8.3 Lindis Biotech Bispecific Antibody Drug Introduction

11.8.4 Lindis Biotech Revenue in Bispecific Antibody Drug Business (2020-2025)

11.8.5 Lindis Biotech Recent Development

11.9 MacroGenics

11.9.1 MacroGenics Company Details

11.9.2 MacroGenics Business Overview

11.9.3 MacroGenics Bispecific Antibody Drug Introduction

11.9.4 MacroGenics Revenue in Bispecific Antibody Drug Business (2020-2025)

11.9.5 MacroGenics Recent Development

11.10 Genmab

11.10.1 Genmab Company Details

11.10.2 Genmab Business Overview

11.10.3 Genmab Bispecific Antibody Drug Introduction

11.10.4 Genmab Revenue in Bispecific Antibody Drug Business (2020-2025)

11.10.5 Genmab Recent Development

11.11 Immunocore Limited

11.11.1 Immunocore Limited Company Details

11.11.2 Immunocore Limited Business Overview

11.11.3 Immunocore Limited Bispecific Antibody Drug Introduction

11.11.4 Immunocore Limited Revenue in Bispecific Antibody Drug Business (2020-2025)

11.11.5 Immunocore Limited Recent Development

11.12 Xencor

11.12.1 Xencor Company Details

11.12.2 Xencor Business Overview

11.12.3 Xencor Bispecific Antibody Drug Introduction

11.12.4 Xencor Revenue in Bispecific Antibody Drug Business (2020-2025)

11.12.5 Xencor Recent Development

11.13 Merck

11.13.1 Merck Company Details

11.13.2 Merck Business Overview

11.13.3 Merck Bispecific Antibody Drug Introduction

11.13.4 Merck Revenue in Bispecific Antibody Drug Business (2020-2025)

11.13.5 Merck Recent Development

11.14 Affimed

11.14.1 Affimed Company Details

11.14.2 Affimed Business Overview

11.14.3 Affimed Bispecific Antibody Drug Introduction

11.14.4 Affimed Revenue in Bispecific Antibody Drug Business (2020-2025)

11.14.5 Affimed Recent Development

11.15 Alphamab

11.15.1 Alphamab Company Details

11.15.2 Alphamab Business Overview

11.15.3 Alphamab Bispecific Antibody Drug Introduction

11.15.4 Alphamab Revenue in Bispecific Antibody Drug Business (2020-2025)

11.15.5 Alphamab Recent Development

11.16 Akeso

11.16.1 Akeso Company Details

11.16.2 Akeso Business Overview

11.16.3 Akeso Bispecific Antibody Drug Introduction

11.16.4 Akeso Revenue in Bispecific Antibody Drug Business (2020-2025)

11.16.5 Akeso Recent Development

11.17 BeiGene

11.17.1 BeiGene Company Details

11.17.2 BeiGene Business Overview

11.17.3 BeiGene Bispecific Antibody Drug Introduction

11.17.4 BeiGene Revenue in Bispecific Antibody Drug Business (2020-2025)

11.17.5 BeiGene Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Roche

Amgen Inc

Sanofi

Pfizer Inc

Johnson & Johnson

Astrazeneca plc

AbbVie

Lindis Biotech

MacroGenics Inc

Genmab

Immunocore Ltd

Xencor

Merck

Affimed NV

Alphamab

Akeso, Inc.

BeiGene Ltd

List of Tables

Table 1. Global Bispecific Antibody Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Fragment-Based

Table 3. Key Players of IgG-Based

Table 4. Global Bispecific Antibody Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Bispecific Antibody Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Bispecific Antibody Drug Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Bispecific Antibody Drug Market Share by Region (2020-2025)

Table 8. Global Bispecific Antibody Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Bispecific Antibody Drug Market Share by Region (2026-2031)

Table 10. Bispecific Antibody Drug Market Trends

Table 11. Bispecific Antibody Drug Market Drivers

Table 12. Bispecific Antibody Drug Market Challenges

Table 13. Bispecific Antibody Drug Market Restraints

Table 14. Global Bispecific Antibody Drug Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Bispecific Antibody Drug Market Share by Players (2020-2025)

Table 16. Global Top Bispecific Antibody Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bispecific Antibody Drug as of 2024)

Table 17. Ranking of Global Top Bispecific Antibody Drug Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Bispecific Antibody Drug Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Bispecific Antibody Drug, Headquarters and Area Served

Table 20. Global Key Players of Bispecific Antibody Drug, Product and Application

Table 21. Global Key Players of Bispecific Antibody Drug, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Bispecific Antibody Drug Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Bispecific Antibody Drug Revenue Market Share by Type (2020-2025)

Table 25. Global Bispecific Antibody Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Bispecific Antibody Drug Revenue Market Share by Type (2026-2031)

Table 27. Global Bispecific Antibody Drug Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Bispecific Antibody Drug Revenue Market Share by Application (2020-2025)

Table 29. Global Bispecific Antibody Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Bispecific Antibody Drug Revenue Market Share by Application (2026-2031)

Table 31. North America Bispecific Antibody Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Bispecific Antibody Drug Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Bispecific Antibody Drug Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Bispecific Antibody Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Bispecific Antibody Drug Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Bispecific Antibody Drug Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Bispecific Antibody Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Bispecific Antibody Drug Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Bispecific Antibody Drug Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Bispecific Antibody Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Bispecific Antibody Drug Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Bispecific Antibody Drug Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Bispecific Antibody Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Bispecific Antibody Drug Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Bispecific Antibody Drug Market Size by Country (2026-2031) & (US$ Million)

Table 46. Roche Company Details

Table 47. Roche Business Overview

Table 48. Roche Bispecific Antibody Drug Product

Table 49. Roche Revenue in Bispecific Antibody Drug Business (2020-2025) & (US$ Million)

Table 50. Roche Recent Development

Table 51. Amgen Company Details

Table 52. Amgen Business Overview

Table 53. Amgen Bispecific Antibody Drug Product

Table 54. Amgen Revenue in Bispecific Antibody Drug Business (2020-2025) & (US$ Million)

Table 55. Amgen Recent Development

Table 56. Sanofi Company Details

Table 57. Sanofi Business Overview

Table 58. Sanofi Bispecific Antibody Drug Product

Table 59. Sanofi Revenue in Bispecific Antibody Drug Business (2020-2025) & (US$ Million)

Table 60. Sanofi Recent Development

Table 61. Pfizer Company Details

Table 62. Pfizer Business Overview

Table 63. Pfizer Bispecific Antibody Drug Product

Table 64. Pfizer Revenue in Bispecific Antibody Drug Business (2020-2025) & (US$ Million)

Table 65. Pfizer Recent Development

Table 66. Johnson & Johnson Company Details

Table 67. Johnson & Johnson Business Overview

Table 68. Johnson & Johnson Bispecific Antibody Drug Product

Table 69. Johnson & Johnson Revenue in Bispecific Antibody Drug Business (2020-2025) & (US$ Million)

Table 70. Johnson & Johnson Recent Development

Table 71. AstraZeneca Company Details

Table 72. AstraZeneca Business Overview

Table 73. AstraZeneca Bispecific Antibody Drug Product

Table 74. AstraZeneca Revenue in Bispecific Antibody Drug Business (2020-2025) & (US$ Million)

Table 75. AstraZeneca Recent Development

Table 76. Abbvie Company Details

Table 77. Abbvie Business Overview

Table 78. Abbvie Bispecific Antibody Drug Product

Table 79. Abbvie Revenue in Bispecific Antibody Drug Business (2020-2025) & (US$ Million)

Table 80. Abbvie Recent Development

Table 81. Lindis Biotech Company Details

Table 82. Lindis Biotech Business Overview

Table 83. Lindis Biotech Bispecific Antibody Drug Product

Table 84. Lindis Biotech Revenue in Bispecific Antibody Drug Business (2020-2025) & (US$ Million)

Table 85. Lindis Biotech Recent Development

Table 86. MacroGenics Company Details

Table 87. MacroGenics Business Overview

Table 88. MacroGenics Bispecific Antibody Drug Product

Table 89. MacroGenics Revenue in Bispecific Antibody Drug Business (2020-2025) & (US$ Million)

Table 90. MacroGenics Recent Development

Table 91. Genmab Company Details

Table 92. Genmab Business Overview

Table 93. Genmab Bispecific Antibody Drug Product

Table 94. Genmab Revenue in Bispecific Antibody Drug Business (2020-2025) & (US$ Million)

Table 95. Genmab Recent Development

Table 96. Immunocore Limited Company Details

Table 97. Immunocore Limited Business Overview

Table 98. Immunocore Limited Bispecific Antibody Drug Product

Table 99. Immunocore Limited Revenue in Bispecific Antibody Drug Business (2020-2025) & (US$ Million)

Table 100. Immunocore Limited Recent Development

Table 101. Xencor Company Details

Table 102. Xencor Business Overview

Table 103. Xencor Bispecific Antibody Drug Product

Table 104. Xencor Revenue in Bispecific Antibody Drug Business (2020-2025) & (US$ Million)

Table 105. Xencor Recent Development

Table 106. Merck Company Details

Table 107. Merck Business Overview

Table 108. Merck Bispecific Antibody Drug Product

Table 109. Merck Revenue in Bispecific Antibody Drug Business (2020-2025) & (US$ Million)

Table 110. Merck Recent Development

Table 111. Affimed Company Details

Table 112. Affimed Business Overview

Table 113. Affimed Bispecific Antibody Drug Product

Table 114. Affimed Revenue in Bispecific Antibody Drug Business (2020-2025) & (US$ Million)

Table 115. Affimed Recent Development

Table 116. Alphamab Company Details

Table 117. Alphamab Business Overview

Table 118. Alphamab Bispecific Antibody Drug Product

Table 119. Alphamab Revenue in Bispecific Antibody Drug Business (2020-2025) & (US$ Million)

Table 120. Alphamab Recent Development

Table 121. Akeso Company Details

Table 122. Akeso Business Overview

Table 123. Akeso Bispecific Antibody Drug Product

Table 124. Akeso Revenue in Bispecific Antibody Drug Business (2020-2025) & (US$ Million)

Table 125. Akeso Recent Development

Table 126. BeiGene Company Details

Table 127. BeiGene Business Overview

Table 128. BeiGene Bispecific Antibody Drug Product

Table 129. BeiGene Revenue in Bispecific Antibody Drug Business (2020-2025) & (US$ Million)

Table 130. BeiGene Recent Development

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

Table 134. Authors List of This Report

List of Figures

Figure 1. Bispecific Antibody Drug Picture

Figure 2. Global Bispecific Antibody Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Bispecific Antibody Drug Market Share by Type: 2024 VS 2031

Figure 4. Fragment-Based Features

Figure 5. IgG-Based Features

Figure 6. Global Bispecific Antibody Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Bispecific Antibody Drug Market Share by Application: 2024 VS 2031

Figure 8. Cancer Case Studies

Figure 9. Haemophilia Case Studies

Figure 10. Other Diseases Case Studies

Figure 11. Bispecific Antibody Drug Report Years Considered

Figure 12. Global Bispecific Antibody Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Bispecific Antibody Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Bispecific Antibody Drug Market Share by Region: 2024 VS 2031

Figure 15. Global Bispecific Antibody Drug Market Share by Players in 2024

Figure 16. Global Top Bispecific Antibody Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bispecific Antibody Drug as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Bispecific Antibody Drug Revenue in 2024

Figure 18. North America Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Bispecific Antibody Drug Market Share by Country (2020-2031)

Figure 20. United States Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Bispecific Antibody Drug Market Share by Country (2020-2031)

Figure 24. Germany Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Bispecific Antibody Drug Market Share by Region (2020-2031)

Figure 32. China Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Bispecific Antibody Drug Market Share by Country (2020-2031)

Figure 40. Mexico Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Bispecific Antibody Drug Market Share by Country (2020-2031)

Figure 44. Turkey Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Bispecific Antibody Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Roche Revenue Growth Rate in Bispecific Antibody Drug Business (2020-2025)

Figure 48. Amgen Revenue Growth Rate in Bispecific Antibody Drug Business (2020-2025)

Figure 49. Sanofi Revenue Growth Rate in Bispecific Antibody Drug Business (2020-2025)

Figure 50. Pfizer Revenue Growth Rate in Bispecific Antibody Drug Business (2020-2025)

Figure 51. Johnson & Johnson Revenue Growth Rate in Bispecific Antibody Drug Business (2020-2025)

Figure 52. AstraZeneca Revenue Growth Rate in Bispecific Antibody Drug Business (2020-2025)

Figure 53. Abbvie Revenue Growth Rate in Bispecific Antibody Drug Business (2020-2025)

Figure 54. Lindis Biotech Revenue Growth Rate in Bispecific Antibody Drug Business (2020-2025)

Figure 55. MacroGenics Revenue Growth Rate in Bispecific Antibody Drug Business (2020-2025)

Figure 56. Genmab Revenue Growth Rate in Bispecific Antibody Drug Business (2020-2025)

Figure 57. Immunocore Limited Revenue Growth Rate in Bispecific Antibody Drug Business (2020-2025)

Figure 58. Xencor Revenue Growth Rate in Bispecific Antibody Drug Business (2020-2025)

Figure 59. Merck Revenue Growth Rate in Bispecific Antibody Drug Business (2020-2025)

Figure 60. Affimed Revenue Growth Rate in Bispecific Antibody Drug Business (2020-2025)

Figure 61. Alphamab Revenue Growth Rate in Bispecific Antibody Drug Business (2020-2025)

Figure 62. Akeso Revenue Growth Rate in Bispecific Antibody Drug Business (2020-2025)

Figure 63. BeiGene Revenue Growth Rate in Bispecific Antibody Drug Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Monoclonal Antibody Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antibody Drug Conjugate Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Clinical Grade Antibody Portfolio Market Research Report 2025

Biopharma Cosmetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antibody Drug Conjugation Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

BiSpecific MAbS Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

α Bisabolol Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Bispecific Antibody Technology Platform Market Research Report 2025

Global Immune Drugs Market Insights Forecast to 2030

Generic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Fusion Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Still s Disease Treatment Market Research Report 2025

Next Generation Immunology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Marine Biopharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Inspection System for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antibody Drug Conjugate Linker And Conjugation Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Generic and Biosimilar Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

120 Pages

Type: Report

Code: QYRE-Auto-19G16926

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ELISA Immunoassay Plates Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-7Z17064

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ready-to-Use ELISA Kits Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-20P20045

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Moxidectin Injection Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-3Z19977

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Bispecific Antibody Drug Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-18C5839

Global Bispecific Antibody Drug Market Research Report 2025

FEATURED COMPANIES

Bispecific Antibody Drug Market Size

Bispecific Antibody Drug Market

Scope of Bispecific Antibody Drug Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Bispecific Antibody Drug Market report?

What are the Application segmentation covered in the Bispecific Antibody Drug Market report?

What are the Type segmentation covered in the Bispecific Antibody Drug Market report?

Recommended Reports

Pharmaceutical Drugs

Pharmaceutical Equipment

Diagnostics & Therapies

FEATURED COMPANIES

RELATED REPORTS